Genetic variations in EGF and EGFR and glioblastoma outcome

Neuro-Oncology

Volumn 12, Issue 8, 2010, Pages 815-821

  Sjöström, Sara ^a   Andersson, Ulrika ^a   Liu, Yanhong ^b   Brännström, Thomas ^c   Broholm, Helle ^d   Johansen, Christoffer ^e   Collatz Laier, Helle ^e,f   Henriksson, Roger ^a   Bondy, Melissa ^b   Melin, Beatrice ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^f SLAGELSE HOSPITAL   (Denmark)

Author keywords

EGF; EGFR; Glioblastoma; Outcome; Polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GLIOBLASTOMA; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN TUMOR; GENETICS; GENOTYPE; MIDDLE AGED; MORTALITY; POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; BRAIN NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GENOTYPE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS; YOUNG ADULT;

EID: 78149473041     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq018     Document Type: Article

References (21)

1. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res. 2004;64:1220-1223.
2. Vauleon E, Auger N, Benouaich-Amiel A, et al. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet. 2007;172:33-37.
3. Scheurer ME, Amirian E, Cao Y, et al. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res. 2008;14:6640-6646.
4. Carpentier C, Lejeune J, Gros F, et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol. 2007;84: 249-253.
5. Andersson U, Osterman P, Sjostrom S, et al. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer. 2009;125:968-972.
6. Okcu MF, Selvan M, Wang LE, et al. Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res. 2004;10:2618-2625.
7. Costa BM,Ferreira P,Costa S, et al. Association between functionalEGF+61 polymorphism and glioma risk. Clin Cancer Res. 2007;13:2621-2626.
8. Nagane M, Lin H, Cavenee WK, Huang HJ. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett. 2001;162(suppl):S17-S21.
9. Andersson U, Guo D, Malmer B, et al. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol. 2004;108:135-142.
10. Wrensch M, Wiencke JK, Wiemels J, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006;66:4531-4541.
11. Cardis E, Richardson L, Deltour I, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22:647-664.
12. Malmer BS, Feychting M, Lonn S, et al. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol. 2007;82:229-237.
13. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114:97-109.
14. Curran WJ, Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704-710.
15. Krex D, Klink B, Hartmann C, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130:2596-2606.
16. Cancer Genome Atlas Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-1068.
17. Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer. 1999; 79:1392-1398.
18. Nishikawa R, Ji XD, Harmon RC, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA. 1994;91:7727-7731.
19. Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 2005;65:4051-4058.
20. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64:6892-6899.
21. Dittmann K, Mayer C, Kehlbach R, Rodemann HP. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer. 2008;7:69.